Gritstone Oncology’s (NASDAQ:GRTS) quiet period is set to end on Wednesday, November 7th. Gritstone Oncology had issued 6,666,667 shares in its IPO on September 28th. The total size of the offering was $100,000,005 based on an initial share price of $15.00. During the company’s quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.